Probe Name	A-DA					Probe Info
Probe concentration	5 uM
Criteria	Quantification: Probe vs (Probe+Competitor)
Quantitative Method	SILAC
Competitor Name	Ro 48-8071					Competitor Info
Competitor Concentration	5 uM
In Vivo Experiment Model	Model Type			Living cell
	Derived Tissue			Lung
	Disease Model		Lung adenocarcinoma [ICD-11:2C25]
	Model Name		Human lung adenocarcinoma cells (A-549)

Target ID	Target Name					Binding Ratio
LDTP04183	Lanosterol synthase (LSS)					20.0
LDTP06325	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EBP)					16.0
LDTP07766	Ceramide synthase 6 (CERS6)					2.7
LDTP03736	Prostaglandin G/H synthase 2 (PTGS2)					2.5
LDTP13282	Prenylcysteine oxidase 1 (PCYOX1)					2.5
LDTP06200	Delta(14)-sterol reductase LBR (LBR)					2.3
LDTP11124	Ferroptosis suppressor protein 1 (AIFM2)					2.2
LDTP08979	Prostaglandin reductase 2 (PTGR2)					2.1
LDTP04388	Palmitoyl-protein thioesterase 1 (PPT1)					2.1
LDTP10077	Patatin-like phospholipase domain-containing protein 2 (PNPLA2)					2.0

Target ID	Target Name					Binding Ratio
LDTP06945	Sigma intracellular receptor 2 (TMEM97)					20.0
LDTP00541	NPC intracellular cholesterol transporter 1 (NPC1)					2.8
LDTP02215	Prosaposin (PSAP)					2.3
LDTP05394	Caveolin-1 (CAV1)					2.2
LDTP11214	Transmembrane protein 208 (TMEM208)					2.1
LDTP14002	Transmembrane emp24 domain-containing protein 3 (TMED3)					2.1

Target ID	Target Name					Binding Ratio
LDTP03772	Basigin (BSG)					2.4

1	A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. Cell. 2015 Jun 18;161(7):1668-80. doi: 10.1016/j.cell.2015.05.045.